This event is presented in collaboration with the AACC Critical and Point-of-Care Testing Division and the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC).
Plan to join us for the 27th International CPOCT Symposium, which will focus on the current and future role of point-of-care testing in a healthcare environment with an emphasis on value and quality of care.
You will learn how point-of-care testing contributes to healthcare value through faster result turnaround time, lower testing costs, improved patient linkage to care and outcomes, and greater satisfaction for patients and healthcare providers.
Session topics will address public health and disease prevention, diagnosis and monitoring disease for the critically ill, at-home patient self-management, direct-to-consumer testing, and new/emerging technologies.
Registration fee includes conference materials, breakfasts, lunches, and evening receptions.
Program
Photos and Credentials of Speakers
*Program is subject to change
Wednesday, September 26, 2018
- 5:30 – 6:30 pm WELCOME RECEPTION
Thursday, September 27, 2018
- 8:30 – 8:45 am OPENING REMARKS. Leslie Donato, PhD (Committee chair); Mayo Clinic, Rochester, MN
- 8:45 – 9:20 am KEYNOTE PRESENTATION. The Value of POCT in Patient Diagnosis and Improved Clinical Outcomes. Keynote Speaker: Danielle Freedman, MB BS; Luton & Dunstable University Hospital, Luton, United Kingdom
- 9:20 – 9:30 am Q&A with Dr. Freedman
SESSION 1: POCT IN PUBLIC HEALTH AND DISEASE PREVENTION. Moderator: Nichole Korpi-Steiner, PhD; University of North Carolina Hospitals
- 9:30 – 9:35 am Moderator introduction to session
- 9:35 – 10:05 am HIV testing and Linkage to Care
Debbie Mohammed, PhD, MS, MPH; William Paterson University, Wayne, NJ - 10:05 – 10:10 am Q&A with Dr. Mohammed
- 10:10 – 10:35 am BREAK – NETWORKING AND VISIT EXHIBITORS
- 10:35 – 11:05 am Efficacy of Child-Parent Familial Cholesterol Screening in Primary Care
Amy Peterson, MD; University of Wisconsin School of Medicine and Public Health - 11:05 – 11:10 am Q&A with Speaker
- 11:10 – 11:40 am Lead Screening: Effectiveness and Analytical Considerations
Douglas Stickle, PhD; Jefferson University Hospital, Philadelphia, PA - 11:40 – 11:45 am Q&A with Dr. Stickle
- 11:45 – 11:55 am Point of Care Creatinine to Assist Clinical Decision Making in Suspected Sepsis in the Community.
Dimitris Poulikakos, MD; Salford Royal NHS Foundation Trust - 11:55 am – 12:00 pm Q&A with Dimitrios Poulikakos
- 12:15 – 1:45 pm LUNCH AND VISIT EXHIBITORS
SESSION 2: DISEASE DIAGNOSIS AND MONITORING FOR THE CRITICALLY ILL
Moderator: Brad Karon, MD, PhD; Mayo Clinic, Rochester, MN
- 1:45 – 1:50 pm Moderator introduction to session
- 1:50 – 2:20 pm The Benefits and Challenges of Point of Care Testing for Respiratory Tract Infection. Leslie Wolf, PhD; Louisville Metro Public Health and Wellness Laboratory, Louisville, KY
- 2:20 – 2:25 pm Q&A with Dr. Wolf
- 2:25 – 2:55 pm Hemostasis Testing for Liver Transplant. Antonio Leon-Justel, MD; University Hospital, Institute of Biomedicine of Seville, Spain
- 2:55 – 3:00 pm Q&A with Dr. Leon-Justel
- 3:00 – 3:25 pm BREAK – NETWORKING AND VISIT EXHIBITORS
- 3:25 – 3:55 pm Update on biomarkers for acute kidney injury. Chirag Parikh, MD, PhD; Johns Hopkins University Medical Institutions, Baltimore, MD
- 3:55 – 4:00 pm Q&A with Dr. Parikh
- 4:00 – 4:10 pm Clinical Impact of an Autocorrecting Blood Glucose Monitoring System in the Severely Burned Adult Population: A Pre- and Post-Implementation Comparison Study. Nam Tran, MS, MAS, PhD; University of California, Davis, Davis, CA
- 4:10 – 4:15 pm Q&A with Dr. Tran
- 4:15 – 4:25 pm Implementation and Ongoing Support of POCT in the World’s Only Stroke Ambulance for Rural Stroke Care. Anna Füezéry, PhD; Royal Alexandra Hospital, Edmonton, Alberta, Canada
- 4:25 – 4:30 pm Q&A with Dr. Füezéry
- 4:30 – 5:30 pm RECEPTION WITH POSTER VIEWING AND VISIT EXHIBITORS
Friday, September 28, 2018
8:30 – 9:30 am CORPORATE SUPPORTER PRESENTATIONS (Industry Viewpoints)
SESSION 3: POCT IN AT-HOME PATIENT SELF-MANAGEMENT FOR ACUTE AND CHRONIC DISEASES. Moderator: Rob Nerenz, PhD; Dartmouth-Hitchcock Medical Center, Hanover, NH
- 9:30 – 9:35 am Moderator introduction to session
- 9:35 – 10:05 am Continuous Glucose Monitors – Improved Outcomes, Challenges for Laboratorians. Timothy Bailey, MD; Advanced Metabolic Care and Research Institute, University of California, San Diego, CA
- 10:05 – 10:10 am Q&A with Dr. Bailey
- 10:10 – 10:40 am TBD
Speaker TBD - 10:35 – 10:45 am Q&A withTBD
- 10:45 – 11:10 am BREAK – NETWORKING AND VISIT EXHIBITORS
- 11:10 – 11:40 am Monitoring Creatinine Following Renal Transplant. Celine van Lint, MSc; Leiden University Medical Center, Netherlands
- 11:40 – 11:45 am Q&A with Dr. van Lint
- 11:45 – 1:30 pm LUNCH AND VISIT EXHIBITORS
SESSION 4: POCT AND DIRECT TO CONSUMER TESTING. Moderator: T. Scott Isbell, PhD; St. Louis University School of Medicine, MO
- 1:30 – 1:35 pm Moderator introduction to session
- 1:35 – 1:55 pm Digital Health and the Engaged Patient. David Grenache, PhD; TriCore Reference Laboratories, NM
- 1:55 – 2:15 pm Legal Perspectives on Direct to Consumer Testing. Timothy Allen, MD, JD; University of Mississippi, Jackson, MS
- 2:15 – 2:35 pm Ethical Perspectives on Direct to Consumer Testing. Anita Ho, PhD, MPH; The University of British Columbia, Vancouver, Canada
- 2:35 – 3:05 pm Panel Discussion and Q&A with Session 4 speakers
- 3:05 – 3:35 pm NETWORKING AND VISIT EXHIBITORS
- 5:30 – 7:30 pm AWARDS RECEPTION at the National Press Club
Saturday, September 29, 2018
SESSION 5: NEW AND EMERGING POCT TECHNOLOGIES. Moderator: Brenda Suh-Lailam, PhD; Lurie Children’s Hospital, Chicago, IL
- 8:30 – 8:35 am Moderator introduction to session
- 8:35 – 9:05 am Ambient Ionization Mass Spectrometry for Point-of-Care Diagnostics. Graham Cooks, PhD; Purdue University, West Lafayette, IN
- 9:05 – 9:15 am Q&A with Dr. Cooks
- 9:15 – 9:45 am Genetic Testing Made Possible with a Smartphone
Syed Hashsham, PhD; Michigan State University, Lansing, MI - 9:45 – 9:55 am Q&A with Dr. Hashsham
- 9:55 – 10:15 am BREAK – NETWORKING and VISIT EXHIBITORS
- 10:15 – 10:45 am Sweat Analysis using Microfluidics. John Rogers, PhD; Northwestern University School of Engineering, Chicago, IL
- 10:45 – 10:55 am Q&A with Dr. Rogers
- 10:55 – 11:05 am Reducing Hospital Length of Stay and Readmission Rates in Surgical Inpatients with Diabetes Mellitus Through Improved Glycaemic Control Using an Automated Glucose System.
Irene Kopp, NP/CDE; Nepean Diabetes Service, Penrith NSW, Australia - 11:05 – 11:10 am Q&A with Irene Kopp
- 11:10 – 11:20 am CLOSING REMARKS. Leslie Donato, PhD (Committee chair); Mayo Clinic, Rochester, MN
- 11:20 – 12:45 SPECIAL PRESENTATION FROM THE INTERNATIONAL FEDERATION OF CLINICAL CHEMISTRY (IFCC) Glucose monitoring in critically ill patients; what do we need to know? An overview of the IFCC report: “How Should Glucose Meters be Evaluated for Critical Care?” Cynthia Bowman, MD; Baystate Health, Springfield, MA. Sean Cunningham, PhD, EuSpLM; Dublin, Ireland
